市占率第一！有色金属检测“小巨人”今日申购，另有一只新股上市丨打新早知道

Group 1: North Mining Testing (北矿检测) - North Mining Testing, established in 2016, is a leading domestic institution in the research and service of non-ferrous metal inspection and testing technology [2][6] - The company plans to issue shares at a price of 6.70 yuan per share, with a market capitalization of 1.44 billion yuan and an issuance P/E ratio of 14.99 [3][5] - The company aims to invest 1.44 billion yuan (71.89%) in advanced testing instrument base and capability construction, and 0.56 billion yuan (28.11%) in supplementing working capital [5] - North Mining Testing is involved in the formulation and revision of numerous international and national standards, indicating its strong position in the industry [6] - Despite being the market leader in non-ferrous metal inspection, the company warns of risks related to market space limitations and potential performance declines due to industry transaction scale fluctuations [6][7] Group 2: Danna Biotechnology (丹娜生物) - Danna Biotechnology, founded in 2014, specializes in the early diagnosis of invasive fungal diseases and other pathogen microorganisms [8][10] - The company plans to issue shares at a price of 17.10 yuan per share, with a market capitalization of 1 billion yuan and an issuance P/E ratio of 11.75 [9] - Danna Biotechnology intends to allocate 1 billion yuan (73.10%) for headquarters construction and 0.37 billion yuan (26.90%) for new product development [10] - The company holds a 30% market share in the invasive fungal disease diagnostic reagent market in China, primarily serving tertiary hospitals [10] - Danna Biotechnology's main product relies on horseshoe crab blood, which is now a nationally protected species, posing potential supply risks [11]